Stocks to sell

From its stellar performance in 2021 to deflating in 2022, the biotech sector continued its stagnation into 2023, highlighting some pharma stocks to avoid. Year-to-date, the S&P Biotechnology Select Industry Index has dropped by 4%. Likewise, the number of biotech firms shrunk by 3% in 2023. Although overlapping with the biotech sector, pharma stocks have
0 Comments
Consumer interest has definitely has started to shift away from EV stocks with many investors choosing to sell them in favor of conventional combustion engine companies. Everything from government subsidies to concerns about climate change has spurred growth in the sector. However, since the beginning of the U.S. Federal Reserve’s 2022 rate hike cycle, the
0 Comments
Investors should always pay close attention to stocks with lowered price targets. Not only can that lowered target highlight potential danger, but it can also highlight a potential short opportunity to be well aware of. Often, downgraded and downward price revisions are influenced by company fundamentals, including financial health and future growth. They can also
0 Comments
It’s fair to assert that EV stalks are dangerous overall. The sector has been maligned throughout 2024 and continues to face ongoing issues. The electric vehicle industry continues to evolve but is facing what can optimistically be called a rough patch. Thus, many investors would classify any and all EV stocks as being dangerous. Yet, as with any sector, there are bound to be
0 Comments
Rivian Automotive (NASDAQ:RIVN) is the next electric vehicle manufacturer to report quarterly results. While not for certain that Rivian stock surges once the latest numbers hit the street, a post-earnings rally isn’t out of the question. Peer Lucid Group (NASDAQ:LCID) may have tanked after its latest quarterly earnings release, but Rivian’s deliveries beat could in
0 Comments
Once, the saying “Don’t bet against the mouse” was commonplace when advising investors to avoid trading against Disney (NYSE:DIS). Increasingly, that maxim is falling out of favor and replaced with “Don’t bet against Elon Musk.” Looking at Elon Musk’s many projects with a clear, fair and impartial perspective is nearly impossible today. That’s because political
0 Comments
Although geopolitical tensions are high and defense spending is generally on the rise globally, not all defense stocks companies will benefit. Some defense contractors may face challenges. Those include supply chain disruptions, labor shortages or reputational risks that could impact performance and prices. Moreover, the defense industry is heavily dependent on government contracts and budget
0 Comments
It has been a few volatile weeks for U.S. equities. After ending the first quarter of 2024 with significant gains, the S&P500 and Nasdaq posted some of their worst months in a while in April. These major indices fell 2.63% and 2.42%, respectively. This dip has led to investors reevaluating their portfolios to consider if
0 Comments
The Financial Select Sector SPDR Fund ETF (NYSEARCA:XLF) is down by approximately 3% month-over-month, illustrating the interim negativity attached to the financial sector.  Interest rate uncertainty paired with inconsistent real economic factors will lead to a sectoral drawdown. Sure, some variables might combat my outlook. However, the aforementioned variables may cause credit spreads to surge in the coming months, leading to a
0 Comments